Last updated at 06 Jul 2024 10:47 AM
Director
DIN: 01961881
Ravi Rao Udayavar is currently associated with 2 companies as Director. They serve as a Director at PRANAV LABORATORIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01961881.Ravi Rao Udayavar has previously been associated with 2 companies in roles such as Additional Director and Director.Ravi Rao Udayavar is currently involved in 1 different role. Their most recent position is with MOTHER INDIA PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Ravi Rao Udayavar was appointed to as a director was PRANAV LABORATORIES PRIVATE LIMITED. Ravi Rao Udayavar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ravi Rao Udayavar is currently associated with 2 companies as Director. They serve as a Director at PRANAV LABORATORIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01961881.Ravi Rao Udayavar has previously been associated with 2 companies in roles such as Additional Director and Director.Ravi Rao Udayavar is currently involved in 1 different role. Their most recent position is with MOTHER INDIA PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Ravi Rao Udayavar was appointed to as a director was PRANAV LABORATORIES PRIVATE LIMITED. Ravi Rao Udayavar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
5y 8m 2y 10m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| PRANAV LABORATORIES PRIVATE LIMITED | Director | 26-May-2005 |
| MOTHER INDIA PHARMACEUTICALS PRIVATE LIMITED | Director | 30-Sep-2023 |